[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-338339-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-338339-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","kif18a-promotes-cervical-squamous-cell-carcinoma-progression-by-activating-the-pi3kakt-pathway-through-upregulation-of-cenpe-research-paper-abstract","KIF18A promotes cervical squamous cell carcinoma progression by activating the PI3K/AKT pathway through upregulation of CENPE - Research paper abstract","","KIF18A is investigated for its role in cervical squamous cell carcinoma (CESC), where its function has remained unclear despite reports linking KIF18A to other malignancies. Bioinformatics using public datasets, plus clinical validation via western blotting and qRT-PCR, evaluate expression changes and mechanistic pathways. Functional assays (wound-healing, flow cytometry, CCK-8, Transwell) test impacts on growth, migration, invasion, apoptosis, and PI3K/AKT activation, linking KIF18A to CENPE and suggesting biomarker and therapeutic target potential.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/kif18a-promotes-cervical-squamous-cell-carcinoma-progression-by-activating-the-pi3kakt-pathway-through-upregulation-of-cenpe-research-paper-abstract/338339/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/kif18a-promotes-cervical-squamous-cell-carcinoma-progression-by-activating-the-pi3kakt-pathway-through-upregulation-of-cenpe-research-paper-abstract/338339.png","ImageObject",300,407,{"name":42,"@type":43},"Sage","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main focus of the study on KIF18A in CESC?","Question",{"text":63,"@type":64},"The study examines how KIF18A affects CESC progression and identifies the underlying molecular mechanism.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were KIF18A and CENPE expression levels evaluated in clinical samples?",{"text":68,"@type":64},"Expression levels in clinical CESC samples were assessed using western blotting and qRT-PCR.",{"name":70,"@type":61,"acceptedAnswer":71},"What mechanisms and pathways are linked to KIF18A in CESC progression?",{"text":72,"@type":64},"KIF18A upregulation activates the PI3K/AKT signaling pathway, suppresses apoptosis, and shows a positive association with CENPE in CESC cells.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},338339,1790211050,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Cancer Biomarkers 41 (2024) 165–178 165  \nDOI 10.3233/CBM-240074 IOS Press  \nKIF18A promotes cervical squamous cell carcinoma progression by activating the PI3K/AKT pathway through upregulation of CENPE  \nFengyi Sun and Tiantian Zhao􀀃  \nDepartment of Gynecology, Weifang People's Hospital, Weifang, Shandong, China  \nReceived 26 March 2024 Accepted 19 July 2024  \nAbstract.  \nBACKGROUND: Cervical cancer is a prevalent malignancy that signiﬁcantly contributes to morbidity and mortality rates among women in developing nations. Although the association of KIF18A with various cancers has been established, its role in cervical squamous cell carcinoma (CESC) remains elusive.  \nMETHODS: The KIF18A impact on the progression of CESC and its underlying mechanism were investigated through comprehensive bioinformatics analysis utilizing publicly available datasets. The levels of KIF18A and CENPE were assessed in clinical CESC samples through western blotting and qRT-PCR. To discover the role and molecular pathways of KIF18A in CESC, a combination of experimental approaches, including wound-healing, ﬂow cytometry, CCK-8, and Transwell assay, were employed. RESULTS: Our results demonstrate a signiﬁcant KIF18A expression upregulation in CESC tissues in contrast to healthy tissues. In vitro, KIF18A upregulation was found to enhance cell growth, migration, and invasion and activate the PI3K/AKT signaling pathway while concurrently suppressing apoptosis. Conversely, downregulating KIF18A exhibited contrasting effects. Mechanistically, we observed a positive signiﬁcant connection between KIF18A and CENPE in CESC cells.  \nCONCLUSION: KIF18A promotes tumor growth in CESC by modulating the PI3K/AKT signaling pathway through regulation of CENPE, making it a potential biomarker for diagnosis and prognosis as well as a therapeutic target.  \nKeywords: KIF18A, CENPE, Cervical squamous cell carcinoma, PI3K/AKT pathway  \n1. Introduction  \nCervical cancer is a malignancy tumor that affects the reproductive system of the female and is a major health concern for women worldwide, ranking second only to breast cancer in its effect on women's health. Despite extensive efforts to promote vaccination and implement cervical cancer screening programs, the global incidence of new cases reached a staggering 604,127 in  \n􀀃 Corresponding author: Tiantian Zhao, Department of Gynecology, Weifang People's Hospital Weifang 261041, Shandong, China. [E-mail: haichunyang@outlook.com](E-mail: haichunyang@outlook.com).  \n2020, leading to an alarming number of over 341,831 fatalities [1] . Even though individuals diagnosed with cervical malignancy in early stage generally have a favorable prognosis, the potential for an adverse outcome escalates in cases of recurrence or metastasis. Cisplatin-based chemotherapy is a commonly recommended treatment for advanced cervical cancer, yet its efﬁcacy remains suboptimal, with a 5-year overall survival rate of only 68% for patients [2,3] . Cervical squamous cell carcinoma (CESC) constitutes the majority of cervical malignancy cases, with approximately 70%–80% being squamous type and around 20%–25% being adenocarcinomas [4,5] . Therefore, it remains im-  \nISSN 1574-0153 􀀍c 2024 – The authors. Published by IOS Press. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC 4 .0) .  \n166 F. Sun and T. Zhao / KIF18A promotes CESC progression by activating the PI3K/AKT pathway through upregulation of CENPE  \nperative to investigate the pathway underlying CESC development, detect appropriate markers, and explore novel targets for therapeutic intervention.  \nKIF18A, a kinesin superfamily member, functions as a molecular motor powered by ATP hydrolysis to generate force and travel through microtubules [6] . Recently, there has been a rising emphasis in the ﬁeld of molecular oncology research on investigating the expression and signiﬁcance of KIF18A in tumors [7] . It is worth menti","cbCaisoxIU0HiV0f","https://ap.wps.com/l/cbCaisoxIU0HiV0f","pdf",7398178,14,"English","# 1. Introduction\n# 2. Materials and methods\n## 2.1. Bioinformatic analysis","[{\"question\":\"What is the main focus of the study on KIF18A in CESC?\",\"answer\":\"The study examines how KIF18A affects CESC progression and identifies the underlying molecular mechanism.\"},{\"question\":\"How were KIF18A and CENPE expression levels evaluated in clinical samples?\",\"answer\":\"Expression levels in clinical CESC samples were assessed using western blotting and qRT-PCR.\"},{\"question\":\"What mechanisms and pathways are linked to KIF18A in CESC progression?\",\"answer\":\"KIF18A upregulation activates the PI3K/AKT signaling pathway, suppresses apoptosis, and shows a positive association with CENPE in CESC cells.\"}]","KIF18A promotes cervical squamous cell carcinoma progression by activating the PI3K/AKT pathway through upregulation of CENPE - Research paper abstract | PDF",1790023126,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fce1987454be44a7d9169ac7cfe49938.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/26d5b4303130b76d75f9384879d43010.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bda23314555b5da9be32544f8b478fb9.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8de544d588c0583d05b704dc842098da.webp",980,1385]